Table 2. Expression levels of KMTs in the hippocampus.
Gene symbol | Synonyms | Histone substrate | % of Gapdh | F(3,19) | p-value |
---|---|---|---|---|---|
Suv39h1 | KMT1A | H3K9 | 0.6265 | 0.562 | 0.65 |
Suv39h2 | KMT1B | H3K9 | 0.1516 | 6.317 | 0.019* |
Ehmt1 | KMT1D/GLP | H3K9, H1.4K26 | 0.5717 | 1.549 | 0.24 |
Ehmt2 | KMT1C/G9a | H3K9, H1.4K26 | 6.1235 | 1.012 | 0.41 |
Setdb1 | KMTIE | H3K9 | 0.6010 | 2.134 | 0.14 |
Kmt2a | Mll1 | H3K4 | 0.8498 | 0.772 | 0.53 |
Kmt2b | Mll2 | H3K4 | 0.2941 | 0.839 | 0.49 |
Kmt2c | Mll3 | H3K4 | 0.2755 | 1.341 | 0.3 |
Ezh1 | KMT6B | H3K27 | 0.7335 | 0.976 | 0.43 |
Ezh2 | KMT6A | H3K27, H1.4K26 | 0.2959 | 7.468 | 0.04* |
p<0.05.
Dark grey highlighting denotes two KMTs that increased in expression after pilocarpine treatment.